Interestingly, PARP1 activity is indispensable for normal proliferation of mammary tumor cells, in which a gene encoding an HRR factor BRCA1 is mutated, because PARP1 inhibition blocks alternative DNA repair pathways including NHEJ5. Here, BRCA1 is linked to breast cancer.